Report Detail

Request for Sample of this report

Pharma & Healthcare Global Amyotrophic Lateral Sclerosis (ALS) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2776981
    • |
  • 17 January, 2019
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.

Scope of the Report:
The worldwide market for Amyotrophic Lateral Sclerosis (ALS) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Amyotrophic Lateral Sclerosis (ALS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Riluzole
Edaravone (Radicava)
Other

Market Segment by Applications, can be divided into
Hospital
Drugs Store
Other

There are 15 Chapters to deeply display the global Amyotrophic Lateral Sclerosis (ALS) market.
Chapter 1, to describe Amyotrophic Lateral Sclerosis (ALS) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Amyotrophic Lateral Sclerosis (ALS), with sales, revenue, and price of Amyotrophic Lateral Sclerosis (ALS), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Amyotrophic Lateral Sclerosis (ALS), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Amyotrophic Lateral Sclerosis (ALS) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Amyotrophic Lateral Sclerosis (ALS) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Amyotrophic Lateral Sclerosis (ALS) Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Riluzole
      • 1.2.2 Edaravone (Radicava)
      • 1.2.3 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Drugs Store
      • 1.3.3 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Mitsubishi Tanabe Pharma
      • 2.1.1 Business Overview
      • 2.1.2 Amyotrophic Lateral Sclerosis (ALS) Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 Sanofi
      • 2.2.1 Business Overview
      • 2.2.2 Amyotrophic Lateral Sclerosis (ALS) Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 Mylan Pharma
      • 2.3.1 Business Overview
      • 2.3.2 Amyotrophic Lateral Sclerosis (ALS) Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Apotex
      • 2.4.1 Business Overview
      • 2.4.2 Amyotrophic Lateral Sclerosis (ALS) Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 Glemark Generics
      • 2.5.1 Business Overview
      • 2.5.2 Amyotrophic Lateral Sclerosis (ALS) Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 Covis Pharma
      • 2.6.1 Business Overview
      • 2.6.2 Amyotrophic Lateral Sclerosis (ALS) Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 Sun Pharma
      • 2.7.1 Business Overview
      • 2.7.2 Amyotrophic Lateral Sclerosis (ALS) Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 Lunan Pharma
      • 2.8.1 Business Overview
      • 2.8.2 Amyotrophic Lateral Sclerosis (ALS) Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Amyotrophic Lateral Sclerosis (ALS) Manufacturer Market Share in 2017
      • 3.3.2 Top 6 Amyotrophic Lateral Sclerosis (ALS) Manufacturer Market Share in 2017
    • 3.4 Market Competition Trend

    4 Global Amyotrophic Lateral Sclerosis (ALS) Market Analysis by Regions

    • 4.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales and Market Share by Regions (2013-2018)
      • 4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Regions (2013-2018)
    • 4.2 North America Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 4.3 Europe Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 4.5 South America Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)

    5 North America Amyotrophic Lateral Sclerosis (ALS) by Countries

    • 5.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales and Market Share by Countries (2013-2018)
      • 5.1.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Countries (2013-2018)
    • 5.2 United States Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 5.3 Canada Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 5.4 Mexico Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)

    6 Europe Amyotrophic Lateral Sclerosis (ALS) by Countries

    • 6.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales and Market Share by Countries (2013-2018)
      • 6.1.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Countries (2013-2018)
    • 6.2 Germany Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 6.3 UK Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 6.4 France Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 6.5 Russia Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 6.6 Italy Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)

    7 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) by Countries

    • 7.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales and Market Share by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Countries (2013-2018)
    • 7.2 China Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 7.3 Japan Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 7.4 Korea Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 7.5 India Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)

    8 South America Amyotrophic Lateral Sclerosis (ALS) by Countries

    • 8.1 South America Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Amyotrophic Lateral Sclerosis (ALS) Sales and Market Share by Countries (2013-2018)
      • 8.1.2 South America Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Countries (2013-2018)
    • 8.2 Brazil Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 8.3 Argentina Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 8.4 Colombia Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)

    9 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) by Countries

    • 9.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales and Market Share by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Countries (2013-2018)
    • 9.2 Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 9.3 UAE Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 9.4 Egypt Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 9.5 Nigeria Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)
    • 9.6 South Africa Amyotrophic Lateral Sclerosis (ALS) Sales and Growth Rate (2013-2018)

    10 Global Amyotrophic Lateral Sclerosis (ALS) Market Segment by Type

    • 10.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Type (2013-2018)
    • 10.2 Riluzole Sales Growth and Price
      • 10.2.1 Global Riluzole Sales Growth (2013-2018)
      • 10.2.2 Global Riluzole Price (2013-2018)
    • 10.3 Edaravone (Radicava) Sales Growth and Price
      • 10.3.1 Global Edaravone (Radicava) Sales Growth (2013-2018)
      • 10.3.2 Global Edaravone (Radicava) Price (2013-2018)
    • 10.4 Other Sales Growth and Price
      • 10.4.1 Global Other Sales Growth (2013-2018)
      • 10.4.2 Global Other Price (2013-2018)

    11 Global Amyotrophic Lateral Sclerosis (ALS) Market Segment by Application

    • 11.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2013-2018)
    • 11.2 Hospital Sales Growth (2013-2018)
    • 11.3 Drugs Store Sales Growth (2013-2018)
    • 11.4 Other Sales Growth (2013-2018)

    12 Amyotrophic Lateral Sclerosis (ALS) Market Forecast (2018-2023)

    • 12.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Amyotrophic Lateral Sclerosis (ALS) Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Amyotrophic Lateral Sclerosis (ALS) Market Forecast (2018-2023)
      • 12.2.2 Europe Amyotrophic Lateral Sclerosis (ALS) Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Market Forecast (2018-2023)
      • 12.2.4 South America Amyotrophic Lateral Sclerosis (ALS) Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Forecast (2018-2023)
    • 12.3 Amyotrophic Lateral Sclerosis (ALS) Market Forecast by Type (2018-2023)
      • 12.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Share Forecast by Type (2018-2023)
    • 12.4 Amyotrophic Lateral Sclerosis (ALS) Market Forecast by Application (2018-2023)
      • 12.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Amyotrophic Lateral Sclerosis (ALS) . Industry analysis & Market Report on Amyotrophic Lateral Sclerosis (ALS) is a syndicated market report, published as Global Amyotrophic Lateral Sclerosis (ALS) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Amyotrophic Lateral Sclerosis (ALS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,773.56
      		4,160.34
      		5,547.12
      		3,232.92
      		4,849.38
      		6,465.84
      		533,240.40
      		799,860.60
      		1,066,480.80
      		290,371.20
      		435,556.80
      		580,742.40
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo